ID: ALA4069187

Max Phase: Preclinical

Molecular Formula: C32H41FN6O2

Molecular Weight: 560.72

Molecule Type: Small molecule

Representations

Canonical SMILES:  CCN(CC)CCNC(=O)c1ccc(/C=C2\CCn3c2nc2cc(NCCCN4CCCC4)c(F)cc2c3=O)cc1

Standard InChI:  InChI=1S/C32H41FN6O2/c1-3-37(4-2)19-14-35-31(40)24-10-8-23(9-11-24)20-25-12-18-39-30(25)36-28-22-29(27(33)21-26(28)32(39)41)34-13-7-17-38-15-5-6-16-38/h8-11,20-22,34H,3-7,12-19H2,1-2H3,(H,35,40)/b25-20+

Standard InChI Key:  BIKOHJQHBIIHKT-LKUDQCMESA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 560.72

Molecular Weight (Monoisotopic): 560.3275

AlogP: 4.45

#Rotatable Bonds: 12

Polar Surface Area: 82.50

Molecular Species: BASE

HBA: 7

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa:

CX Basic pKa: 9.53

CX LogP: 3.19

CX LogD: -0.42

Aromatic Rings: 3

Heavy Atoms: 41

QED Weighted: 0.32

Np Likeness Score: -1.34

References

1. Shan C, Yan JW, Wang YQ, Che T, Huang ZL, Chen AC, Yao PF, Tan JH, Li D, Ou TM, Gu LQ, Huang ZS..  (2017)  Design, Synthesis, and Evaluation of Isaindigotone Derivatives To Downregulate c-myc Transcription via Disrupting the Interaction of NM23-H2 with G-Quadruplex.,  60  (4): [PMID:28128954] [10.1021/acs.jmedchem.6b01218]

Source

Source(1):

• Scientific Literature